NCT05566951

Brief Summary

This research was planned to evaluate the effectiveness of the technology-based psychosocial empowerment program for home care for children aged 8-18 years with cancer and their parents as a parallel-group randomized controlled study design.The required institutional permission and ethics committee approval was received.The study group of the study consisted of 72 children and parents (intervention group \[n=36\], control group \[n=36\]). Data were collected using the descriptive features form, the General Self-Efficacy Scale-Pediatric Cancer Version, the State-Trait Anxiety Inventory for Children, the Pediatric Cancer Coping Scale, the General Self-Efficacy Scale for parents, the Problem Solving Inventory, and the Psychological Resilience Scale for Parents of Children with Cancer. The data were stored in the SPSS 25 program.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Sep 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

1 year

First QC Date

September 23, 2022

Last Update Submit

April 25, 2023

Conditions

Keywords

CancerChildParentsHome-careEmpowerment

Outcome Measures

Primary Outcomes (6)

  • General Self-Efficacy Scale-Pediatric Cancer Version

    It is a one-dimensional, 10-item scale used to evaluate self-efficacy in children aged 8-18 years with cancer.As the score obtained from the scale increases, the level of self-efficacy also increases.

    Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)

  • State-Trait Anxiety Inventory for Children

    he 'State-Trait Anxiety Scale' for children between the ages of 8-18 was created to determine what the child feels at that moment, and the 'Stait-Trait Anxiety Scale' was created to determine what they usually feel. The higher the score, the higher the anxiety level.

    Change from Baseline level 'State-Trait Anxiety' to 2 months (change is being assessed)

  • Pediatric Cancer Coping Scale

    It was developed to evaluate coping in children aged 7-18 years with cancer diagnosis. The scale consists of 3 sub-dimensions as cognitive coping, problem-focused coping and defensive coping. The higher the score, the higher the coping strategies.

    Change from Baseline level 'Pediatric Cancer Coping Scale' to 2 months (change is being assessed)

  • General Self-Efficacy Scale

    It is a one-dimensional scale developed to evaluate the general self-efficacy level of adults.As the score obtained from the scale increases, the level of self-efficacy also increases.

    Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)

  • Problem Solving Inventory

    It is a scale that measures the problem solving skills of individuals according to the perception of the individual.The inventory consists of three sub-dimensions: Safe in Problem Solving, Approach Avoidance Style and Personal Control.Low scores from the inventory indicate the ability to produce effective solutions to problems, while high scores indicate the inability to find effective solutions to problems.

    Change from Baseline level 'Problem Solving Inventory' to 2 months (change is being assessed)

  • Psychological Resilience Scale for Parents of Children with Cancer

    The Resilience Scale for Parents of Children was developed to examine the resilience status of parents of children aged 0-18 years with cancer diagnosis. The scale consists of 24 items and 4 sub-dimensions. As the score obtained from the scale increases, the level of psychological resilience of the parents increases.

    Change from Baseline level 'Psychological Resilience Scale for Parents of Children with Cancer'' to 2 months (change is being assessed)

Secondary Outcomes (1)

  • SSPedi: Symptom Screening Scale in Pediatric Patients

    While the intervention continues (1 months), the log records of the scale on the website will be evaluated.

Study Arms (2)

Experimental group

EXPERIMENTAL

-The experimental group that applied the technology-based psychosocial program

Other: Psychosocial program

Control group

OTHER

Control group receiving standard care

Other: Standart care

Interventions

A technology-based model-based psychosocial empowerment program will be implemented for parents and children in the control group.

Also known as: Technology-based psychosocial program
Experimental group

Parents and children in the intervention group will be applied standard support approaches to be applied in the center where they receive treatment.

Control group

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • For children's:
  • Children between the ages of 8-18,
  • Those receiving cancer treatment (leukemias and solid tumors) and completing the first 2 months of the treatment process,
  • Children with tablets, android phones and internet access
  • Children whose parents and themselves agree to participate in the study,
  • Children who can continue the study for 4-6 weeks,
  • For primary care parents,
  • Parents who can speak Turkish,
  • Parents who can use computers and android mobile phones,
  • Parents who agreed to participate in the study,
  • Parents who can continue the study for 4-6 weeks,

You may not qualify if:

  • Newly diagnosed children (in induction phase),
  • Children who are in the terminal period or who are treated for relapse,
  • Presence of another important disease (such as chronic disease, psychiatric diagnosis) in the family that may prevent coping, other than the child followed up with the diagnosis of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

NeoplasmsEmpowerment

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
In the research, it was planned to blind the participant and outcome evaluation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

September 23, 2022

First Posted

October 5, 2022

Study Start

September 1, 2023

Primary Completion

September 1, 2024

Study Completion

November 1, 2024

Last Updated

April 27, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

There are no plans to make individual participant data (IPD) available to other researchers.